SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech firesales -- Ignore unavailable to you. Want to Upgrade?


To: Chris08 who wrote (2844)3/26/2014 11:40:24 AM
From: tuck  Respond to of 3661
 
Exelixis' (EXEL) COMET-1 trial given the green light to keep going by DSMB, when investors were hoping it would be stopped early for efficacy, as has happened for competing drugs. Stock off 35% on volume. There is actually some chance this is a buying op/overreaction, but look under the hood.

Cheers, Tuck